| Abstract |
This case aims to document the transformation of Indian Organic Chemicals Limited (a low value-high volume bulk chemical producer) into its new avatar as Innovassynth Technologies (I) Ltd—a niche boutique firm of speciality pharmaceutical chemicals in the life sciences industry. Innovassynth is the first Indian company to establish a new kind of research and development process that contracts co-evolution of capabilities in partnership with large pharma giants like Pfizer and BASF along knowledge-intensive business pathways that are unknown and unfamiliar and first of their kind for the large firm and for Innovassynth. A case of this nature tracks the complexities underpinning the co-evolution of dynamic capabilities, and challenges the conventional resource based view of the firm. Here is an opportunity to study how the firm as a nexus of treaties (in the Aokian framework) engages with normative, existential, phenomenal and hermeneutic primary tasks as conceptualized in the open systems literature. |